Description

Our guest today is Navid Alipour of AI MED GLOBAL. Today we take a look at how AI and precision personalized medicine, even medical imaging, converge with this idea of personalizing treatments. 

Navid tells Mark about his business story and the technology behind his company, AI MED GLOBAL and CureMatch. Some of the main topics we talked about:

• How their AI technology creates faster results for early cancer detection
• How they level the playing field to CureMatch any patient. Making it easier for all patients no matter their background, economic or education gaps 
• How AI Med Global works with Clinical Trials and what is KRR AI technology

Mark asks, “If we had a chance to talk to a patient you're serving, what is their biggest need?”

“Every day we get up and say, how can we do things one day faster? That's someone's life that we’ll potentially impact. And so for me, my wife is a cancer survivor, she has heart disease in the family. That early detection, that knowledge is power and that is what will prolong lives and save lives. So our goal is, let's see how we can do this faster.”

Early Detection

With the help of artificial intelligence, precision medicine, genomics, and a higher computer capacity to process data this leads to the advancements in the convergence of technologies resulting in: 

1. progression-free survival or the overall survival of the patient
2. better detection, treatment, and monitoring. 

CureMatch comes in on the detection side.

• No extra radiation
• No extra discomfort

Leveling the Playing Field

Working with community hospitals like many labs do, the hospital can set up their own CLIA-certified labs so they can take care of their patients right there in their community. 

“We all know those horrible nasty cancers, community hospitals end up sending a lot of patients to these academic institutions. And so what we're trying to do is level the playing field. It doesn't matter about someone's background or wealth or education, we can CureMatch any patient, whether it's at Mayo or MD Anderson or a community hospital in Des Moines.”

“Our AI can turn that general radiologist into a specialist.” 

• Getting technology into the hands of the radiologists and the imaging centers to detect cancer faster and increasing the workflow of radiologists
• It's the same kind of technology behind GPS which gives them a five- to seven-year head start and a competitive advantage.

Clinical Trials and KRR AI Technology

A CureMatch report produced in their database is a proprietary database always being updated. Once a new drug is FDA-cleared, they will add it and have their clinical team work on that curation every day.

The type of artificial intelligence is unique and many people haven't heard of it. It's called K R R AI. 

• It's the same kind of technology behind GPS.
• One patient's cancer does not look like anyone else’s at a molecular level. And so that's where KRR AI comes in. 
• The database is curated so that it gets better and better the more it's used.

Navid’s Business Journey

AI MED GLOBAL is a technology company, not a medical practice.

The business was...